Nothing Special   »   [go: up one dir, main page]

Jump to content

Bambermycin

From Wikipedia, the free encyclopedia
Bambermycin
Chemical structure of moenomycin A, one of the components of bambermycin
Clinical data
Trade namesGainpro
AHFS/Drugs.comFDA Professional Drug Information
Identifiers
CAS Number
DrugBank
UNII
KEGG
E numberE712 (antibiotics) Edit this at Wikidata

Bambermycin (flavomycin) is a complex of antibiotics obtained from Streptomyces bambergiensis and Streptomyces ghanaensis used as a food additive for beef cattle, dairy cattle,[1] poultry and swine.[2] The complex consists mainly of moenomycins A and C.[3]

Bambermycin is a performance-enhancing antibiotic intended and available solely for use in animal nutrition. Its mechanism of action is to inhibit the synthesis of the bacterial wall. Bambermycin is predominantly effective against Gram-positive pathogenic bacteria.[4] However, it does not have significant action against Lactobacillus, Bifidobacterium, and other protective bacteria.[5]

Bambermycin has no precautions or warnings to humans on its label pertaining to mixing and handling and is non-hazardous when used according to label directions.[5] Bambermycin has no withdrawal requirement. Bambermycin is not absorbed by the intestine and no measurable residues are found in edible tissues even when fed at up to 50 times the normal recommended dosage.[5]

Synonyms include flavomycin, flavofosfolipol, flavophospholipol, moenomycin, and the brand name Gainpro.[3]

References

[edit]
  1. ^ "Gainpro-10". drugs.com.
  2. ^ "Flavomycin 4". drugs.com.
  3. ^ a b 6433554 CID 6433554 from PubChem
  4. ^ Page SW (March 2006). "Current use of antimicrobial growth promoters in food animals: the benefits, section 7.1: Bambermycin". In Barug D, de Jong J, Kies AK, Verstegen WM (eds.). Antimicrobial growth promoters: Where do we go from here?. Wageningen Academic Publishers. pp. 33–34. ISBN 9789086865703.
  5. ^ a b c "Products - Huvepharma". www.huvepharma.com. Archived from the original on 2016-03-04. Retrieved 2015-09-01.